Claes Held
Overview
Explore the profile of Claes Held including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
227
Citations
11150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wassberg C, Batra G, Hadziosmanovic N, Hagstrom E, White H, Stewart R, et al.
Eur J Prev Cardiol
. 2024 Aug;
PMID: 39106528
Aim: To investigate associations between psychosocial burden and biomarkers reflecting pathophysiological pathways in patients with chronic coronary syndrome. Methods: Psychosocial (PS) factors were collected from self-assessed questionnaires and biomarkers representing...
12.
Erlinge D, Andersson J, Frobert O, Tornerud M, Bohm F, Held C, et al.
Am Heart J
. 2024 Aug;
277:1-10.
PMID: 39098754
Background: Modern drug-eluting stents have seen significant improvements, yet still create a rigid cage within the coronary artery. There is a 2% to 4% annual incidence of target lesion failure...
13.
Hamo C, Liu R, Wu W, Anthopolos R, Bangalore S, Held C, et al.
Am J Cardiol
. 2024 Jun;
225():118-124.
PMID: 38844195
Cardiometabolic co-morbidities, diabetes (DM), hypertension (HTN), and obesity contribute to cardiovascular disease. Circulating biomarkers facilitate prognostication for patients with cardiovascular disease. We explored the relation between cardiometabolic co-morbidity burden in...
14.
Bonaca M, Bhatt D, Simon T, Fox K, Mehta S, Harrington R, et al.
J Am Coll Cardiol
. 2024 Apr;
83(17):1627-1636.
PMID: 38658101
Background: Ticagrelor reduced major adverse cardiovascular events (MACE) and increased bleeding in patients with type 2 diabetes mellitus (T2DM) and coronary artery disease. Limb events including revascularization, acute limb ischemia...
15.
Bohm F, Mogensen B, Engstrom T, Stankovic G, Srdanovic I, Lonborg J, et al.
N Engl J Med
. 2024 Apr;
390(16):1481-1492.
PMID: 38587995
Background: The benefit of fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains unclear. Methods: In this multinational, registry-based,...
16.
Yndigegn T, Lindahl B, Mars K, Alfredsson J, Benatar J, Brandin L, et al.
N Engl J Med
. 2024 Apr;
390(15):1372-1381.
PMID: 38587241
Background: Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern biomarker-based diagnosis...
17.
Omerovic E, James S, Ramundal T, Frobert O, Linder R, Danielewicz M, et al.
Cardiovasc Revasc Med
. 2024 Apr;
66:43-50.
PMID: 38575449
Background: The registry-based randomized VALIDATE-SWEDEHEART trial (NCT02311231) compared bivalirudin vs. heparin in patients undergoing percutaneous coronary intervention (PCI) for myocardial infarction (MI). It showed no difference in the composite primary...
18.
Leissner P, Held C, Humphries S, Rondung E, Olsson E
Eur J Cardiovasc Nurs
. 2024 Mar;
23(7):720-727.
PMID: 38518740
Aims: While elevated levels of anxiety are associated with worse prognosis of cardiovascular disease (CVD), this association may vary between different aspects of anxiety. The aim of this study was...
19.
Fritz Hansson A, Modica A, Renlund H, Christersson C, Held C, Batra G
Open Heart
. 2024 Mar;
11(1).
PMID: 38429057
Background: Amiodarone is an established treatment for atrial fibrillation (AF) but might interfere with the metabolism of apixaban or warfarin. Therefore, the aim was to investigate the occurrence of major...
20.
Reynolds H, Cyr D, Merz C, Shaw L, Chaitman B, Boden W, et al.
J Am Heart Assoc
. 2024 Feb;
13(5):e029850.
PMID: 38410945
Background: Women with chronic coronary disease are generally older than men and have more comorbidities but less atherosclerosis. We explored sex differences in revascularization, guideline-directed medical therapy, and outcomes among...